cardiovascular benefits of glp-1 Receptor Agonists for the Reduction Atherosclerotic Risk in Patients With Type 2 Diabetes The Many Cardiovascular Benefits of

Hernandez AF, Green JB, Janmohamed S et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Learn why the scale lies and what to measure instead

There is no clinical evidence that tapering provides any benefit before switching

Available from: Mafham M, Preiss D

Aspirations during anesthesia can lead to severe complications such as pneumonia, with factors like a full stomach, compromised protective airway reflexes, and reduced consciousness, thus theoretically heightening the risk in patients taking GLP-1 medications compared with the general population

However, even smaller changes in BMI and BMI percentiles can result in improved MASLD measures